T. L. Yaksh

发表

Action of intrathecal capsaicin and its structural analogues on the content and release of spinal substance P: Selectivity of action and relationship to analgesia

T. Yaksh, K. Jhamandas, V. Go, 1984, Brain Research.

Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.

T. Yaksh, S. Chaplan, J. W. Pogrel, 1995, The Journal of pharmacology and experimental therapeutics.

Spinal glial TLR4‐mediated nociception and production of prostaglandin E2 and TNF

E. Dennis, S. Codeluppi, C. Svensson, 2010, British journal of pharmacology.

Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine

M. Marsala, T. Yaksh, K. Jhamandas, 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat.

A. Malmberg, T. Yaksh, S. Chaplan, 1997, The Journal of pharmacology and experimental therapeutics.

Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine.

T. Yaksh, R. Plant, T. Rudy, 1977, European journal of pharmacology.

Characterization of the Effects of L-4-Chlorokynurenine on Nociception in Rodents.

R. Schwarcz, H. Snodgrass, T. Yaksh, 2017, The journal of pain : official journal of the American Pain Society.

Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors.

T. Yaksh, A. Malmberg, Annika B. Malmberg, 1994, European journal of pharmacology.

Spinal phospholipase A2 in inflammatory hyperalgesia: Role of the small, secretory phospholipase A2

E. Dennis, C. Svensson, X. Hua, 2005, Neuroscience.

Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo

T. Jessell, S. Leeman, T. Yaksh, 1980, Nature.

The Acute Antihyperalgesic Action of Nonsteroidal, Anti-Inflammatory Drugs and Release of Spinal Prostaglandin E2 Is Mediated by the Inhibition of Constitutive Spinal Cyclooxygenase-2 (COX-2) but not COX-1

P. Isakson, C. Svensson, T. Yaksh, 2001, The Journal of Neuroscience.

Inhibition of spinal cytosolic phospholipase A2 expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia

D. H. Kim, C. Svensson, B. Monia, 2008, Neuroscience.

Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.

T. Yaksh, Y. Takano, Tony L. Yaksh, 1992, The Journal of pharmacology and experimental therapeutics.

Mechanisms of antinociception of spinal galanin: how does galanin inhibit spinal sensitization?

I. Kondo, B. Fitzsimmons, X. Hua, 2005, Neuropeptides.

Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids

X. Hua, T. Yaksh, M. Marsala, 1999, Neuroscience.

Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats.

T. Yaksh, M. Yoon, Myung Ha Yoon, 1999, Anesthesiology.

Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.

T. Yaksh, E. Mjanger, T. L. Yaksh, 1991, The Journal of pharmacology and experimental therapeutics.

Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.

J. Cassel, T. Yaksh, R. Dehaven, 1999, The Journal of pharmacology and experimental therapeutics.

Current and Future Issues in the Development of Spinal Agents for the Management of Pain

T. Yaksh, A. Wiese, C. J. Fisher, 2017, Current neuropharmacology.

Interaction of midazolam and morphine in the spinal cord of the rat

T. Yaksh, M. Sabbe, C. Stevens, 1990, Neuropharmacology.

Potent suppression of stretch reflex activity after systemic or spinal delivery of tizanidine in rats with spinal ischemia-induced chronic spastic paraplegia

M. Hefferan, M. Marsala, T. Yaksh, 2011, Neuroscience.

Stimulatory pathways and sites of action of intrathecally administered nicotinic agents.

T. Yaksh, I. Khan, P. Taylor, 1994, The Journal of pharmacology and experimental therapeutics.

Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.

T. Yaksh, C. Stevens, T. L. Yaksh, 1989, The Journal of pharmacology and experimental therapeutics.

Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.

T. Yaksh, C. Stevens, M. Sosnowski, 1989, The Journal of pharmacology and experimental therapeutics.

Inhibition of spinal protein kinase Cα expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance

A. Moore, S. Murray, X. Hua, 2002, Neuroscience.

The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.

X. Hua, T. Yaksh, J. Rivier, 1991, The Journal of pharmacology and experimental therapeutics.

The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.

T. Yaksh, C. Stevens, M. Morón, 1990, The Journal of pharmacology and experimental therapeutics.

Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists.

T. Yaksh, Y. Lee, Tony L. Yaksh, 1996, The Journal of pharmacology and experimental therapeutics.

Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test.

T. Yaksh, A. Malmberg, Annika B. Malmberg, 1994, European journal of pharmacology.

Studies of morphine and D-ala2-D-leu5-enkephalin (DADLE) cross-tolerance after continuous intrathecal infusion in the rat.

T. Yaksh, C. Stevens, Tony L. Yaksh, 1992, Anesthesiology.

Toxicology of baclofen continuously infused into the spinal intrathecal space of the dog.

M. Grafe, T. Yaksh, M. Sabbe, 1993, Neurotoxicology.

Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies.

T. Yaksh, C. Stevens, M. Monasky, 1988, The Journal of pharmacology and experimental therapeutics.